alternative-testing-methods
Latest stories covering alternative-testing-methods, with summaries and links to related coverage.
1 stories · 1 reports · page 1 of 1
Connected topics
Alternatives to Animal Testing Are Finally Taking Off
news
14 min read
Nonanimal methods for drug development and toxicity testing now include human organoids, organs-on-chips, computational models, and AI systems that analyze experimental data. Harvard’s 2010 lung-on-a-chip study used human cells in microfluidic channels and simulated breathing motions; it showed that tissue movement affected uptake of silica nanoparticles. Multi-organ chip systems can link as many as 10 organs, although they do not reproduce human physiology perfectly. U.S. law explicitly authorized nonanimal methods in preclinical drug studies through the FDA Modernization Act 2.0 in late 2022. The FDA said in 2025 that it would seek to make animal studies the exception rather than the norm in drug-safety testing. In September 2026, the agency issued a proposed rule replacing “animal tests” with “nonclinical tests” in drug-development regulations, recognizing validated human-cell systems, organs-on-chips, and computer models when appropriate. NIH announced in 2025 that applicants studying animal models would also need to incorporate nonanimal research. Validation, standardization, cost, data access, and scientific training remain barriers. Emulate reported that its liver-on-a-chip identified about seven-eighths of drugs that passed animal testing but later proved toxic to human livers. Oxford University and Janssen researchers reported that computational heart-cell simulations identified compounds causing a dangerous arrhythmia with 89 percent accuracy, versus 75 percent for animal studies. Many methods still lack rigorous head-to-head evidence across intended uses.